Therapeutic margins in a novel preclinical model of retinitis pigmentosa

Journal of Neuroscience

Volumn 33, Issue 33, 2013, Pages 13475-13483

  Davis, Richard J ^a,b   Hsu, Chun Wei ^a,b   Tsai, Yi Ting ^a,b   Wert, Katherine J ^a,b,d   Sancho Pelluz, Javier ^a,b,e   Lin, Chyuan Sheng ^a,c   Tsang, Stephen H ^a,b  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Edward S Harkness Eye Institute   (United States)

^c Columbia University Medical Center ^*  (United States)

^d Department of Medicine   (United States)

^e UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CYCLIC GMP PHOSPHODIESTERASE; CYCLIC GMP PHOSPHODIESTERASE 6; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOFLUORESCENCE IMAGING; CONTROLLED STUDY; DISEASE SEVERITY; DNA SEQUENCE; ELECTRORETINOGRAPHY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC RECOMBINATION; HISTOLOGY; MALE; MOUSE; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; SOUTHERN BLOTTING;

ANIMALS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 6; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; GENETIC THERAPY; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RETINITIS PIGMENTOSA;

EID: 84881500484     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0419-13.2013     Document Type: Article

References (73)

1. Allocca M, Manfredi A, Iodice C, Di Vicino U, Auricchio A (2011) AAV-mediated gene replacement, either alone or in combination with physical and pharmacological agents, results in partial and transient protection from photoreceptor degeneration associated with betaPDE deficiency. Invest Ophthalmol Vis Sci 52:5713-5719.
2. Badea TC, Wang Y, Nathans J (2003) A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse. J Neurosci 23:2314-2322.
3. Berson EL (1993) Retinitis pigmentosa: the Friedenwald lecture. Invest Ophthalmol Vis Sci 34:1659-1676.
4. Biasco L, Baricordi C, Aiuti A (2012) Retroviral integrationsingene therapy trials. Mol Ther 20:709-716.
5. Bird AC (1995) Retinal photoreceptor dystrophies LI: Edward Jackson Memorial Lecture. Am J Opthalmol 119:543-562.
6. Blanks JC, Johnson LV, Hageman GS (1993) Stage-specific binding of pea- nut agglutinin to aggregates of degenerating photoreceptor cells in the rd mouse retina. Exp Eye Res 57:265-273.
7. Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch JL, Chambon P, Metzger D (1997) Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Natl Acad Sci USA 94:14559-14563.
8. Chang B, Hawes NL, Hurd RE, Davisson MT, Nusinowitz S, Heckenlively JR (2002) Retinal degeneration mutants in the mouse. Vision Res 42:517- 525.
9. Chang MA, Horner JW, Conklin BR, DePinho RA, Bok D, Zack DJ (2000) Tetracycline-inducible system for photoreceptor-specific gene expression. Invest Ophthalmol Vis Sci 41:4281-4287.
10. Cideciyan AV, Jacobson SG, Beltran WA, Sumaroka A, Swider M, Iwabe S, Roman AJ, Olivares MB, Schwartz SB, Komaromy AM, Hauswirth WW, Aguirre GD (2013) Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement. Proc Natl Acad Sci U S A 110:517-525.
11. Curcio CA, Owsley C, Jackson GR (2000) Spare the rods, save the cones in aging and age-related maculopathy. Invest Ophthalmol Vis Sci 41:2015- 2018.
12. Daiger SP, Bowne SJ, Sullivan LS (2007) Perspective on genes and mutations causing retinitis pigmentosa. Arch Ophthalmol 125:151-158.
13. Danciger M, Blaney J, Gao YQ, Zhao DY, Heckenlively JR, Jacobson SG, Farber DB (1995) Mutations in the PDE6B gene in autosomal recessive retinitis pigmentosa. Genomics 30:1-7.
14. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP (1998) Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 8:1323-1326.
15. Davis RJ, Tosi J, Janisch KM, Kasanuki JM, Wang NK, Kong J, Tsui I, Cilluffo M, Woodruff ML, Fain GL, Lin CS, Tsang SH (2008) Functional rescue of degenerating photoreceptors in mice homozygous for a hypomorphic cGMP phosphodiesterase 6 b allele (Pde6bH620Q). Invest Ophthalmol Vis Sci 49:5067-5076.
16. Delyfer MN, Forster V, Neveux N, Picaud S, Le'veillard T, Sahel JA (2005) Evidence for glutamate-mediated excitotoxic mechanisms during photo-receptor degeneration in the rd1 mouse retina. Mol Vis 11:688-696.
17. Deyle DR, Russell DW (2009) Adeno-associated virus vector integration. Curr Opin Mol Ther 11:442-447.
18. Dryja TP, Berson EL (1995) Retinitis pigmentosa and allied diseases: implications of genetic heterogeneity. Invest Ophthalmol Vis Sci 36:1197- 1200.
19. Dryja TP, Rucinski DE, Chen SH, Berson EL (1999) Frequency ofmutations in the gene encoding the alpha subunit of rod cGMP-phosphodiesterase in autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci 40:1859-1865.
20. Dvir L, Srour G, Abu-Ras R, Miller B, Shalev SA, Ben-Yosef T (2010) Autosomal-recessive early-onset retinitis pigmentosa caused by a mutation in PDE6G, the gene encoding the gamma subunit of rod cGMP phosphodiesterase. Am J Hum Genet 87:258-264.
21. Gargini C, Terzibasi E, Mazzoni F, Strettoi E (2007) Retinal organization in the retinal degeneration 10 (rd10) mutant mouse: a morphological and ERG study. J Comp Neurol 500:222-238.
22. Greenstein VC, Duncker T, Holopigian K, Carr RE, Greenberg JP, Tsang SH, Hood DC (2012) Structural and functional changes associated with normal and abnormal fundus autofluorescence in patients with retinitis pig-mentosa. Retina 32:349-357.
23. Grüter O, Kostic C, Crippa SV, Perez MT, Zografos L, Schorderet DF, Munier FL, Arsenijevic Y (2005) Lentiviral vector-mediated gene transfer in adult mouse photoreceptors is impaired by the presence of a physical barrier. Gene Ther 12:942-947.
24. Hameyer D, Loonstra A, Eshkind L, Schmitt S, Antunes C, Groen A, Bindels E, Jonkers J, Krimpenfort P, Meuwissen R, Rijswijk L, Bex A, Berns A, Bockamp E (2007) Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. Physiol Genomics 31:32-41.
25. Hahn LB, Berson EL, Dryja TP (1994) Evaluationofthe gene encoding the G subunit ofrod phosphodiesteraseinretinitis pigmentosa. Invest Ophthal-mol Vis Sci 35:1077-1082.
26. Hart AW, McKie L, Morgan JE, Gautier P, West K, Jackson IJ, Cross SH (2005) Genotype-phenotype correlation of mouse pde6b mutations. Invest Ophthalmol Vis Sci 46:3443-3450.
27. Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368: 1795-1809.
28. Hirate J, Horikoshi I, Watanabe J, Ozeki S (1984) Effectof hypothermia and ether anesthesiaonthe dispositionsofcreatinine and urea inmice.J Phar-macobiodyn 7:883-890.
29. Huang SH, Pittler SJ, Huang X, Oliveira L, Berson EL, Dryja TP (1995) Autosomal recessive retinitis pigmentosa caused by mutations in the alpha subunit of rod cGMP phosphodiesterase. Nat Genet 11:468-471.
30. Huang X, Yang Y (2009) Innate immune recognition of viruses and viral vectors. Hum Gene Ther 20:293-301.
31. Jackson GR, Owsley C, Curcio CA (2002) Photoreceptor degeneration and dysfunctioninaging and age-related maculopathy. Ageing Res Rev 1:381- 396.
32. Kedzierski W, Bok D, Travis GH (1998) Non-cell-autonomous photorecep-tor degeneration in rds mutant mice mosaic for expression of a rescue transgene. J Neurosci 18:4076-4082.
33. Kellendonk C, Tronche F, Casanova E, Anlag K, Opherk C, Schütz G (1999) Inducible site-specific recombination in the brain. J Mol Biol 285:175-182.
34. Kitzman JO, Snyder MW, Ventura M, Lewis AP, Qiu R, Simmons LE, Gam-mill HS, Rubens CE, Santillan DA, Murray JC, Tabor HK, Bamshad MJ, Eichler EE, Shendure J (2012) Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 4:137-176.
35. Klein R, Rowland ML, Harris MI (1995) Racial/ethnic differences in age-related maculopathy: Third National Health and Nutrition Examination Survey. Ophthalmology 102:371-381.
36. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M (1999) Age-related maculopathy in a multiracial United States population: The National Health and Nutrition Examination Survey III. Ophthalmology 106:1056-1065.
37. Lakso M, Sauer B, Mosinger B Jr, Lee EJ, Manning RW, Yu SH, Mulder KL, Westphal H (1992) Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 89:6232-6236.
38. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, Jenkins NA, Copeland NG (2001) A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56-65.
39. Lima LH, Cella W, Greenstein VC, Wang NK, Busuioc M, Smith RT, Yan-nuzzi LA, Tsang SH (2009) Structural assessment of hyperautofluores-cent ring in patients with retinitis pigmentosa. Retina 29:1025-1031.
40. Lima LH, Burke T, Greenstein VC, Chou CL, Cella W, Yannuzzi LA, Tsang SH (2012) Progressive constriction of the hyperautofluorescent ring in retinitis pigmentosa. Am J Ophthalmol 153:718-727, 727 e1-2.
41. Liu MM, Tuo J, Chan CC (2011) Gene therapy for ocular diseases. Br J Ophthalmol 95:604-612.
42. McCarrick JW 3rd, Parnes JR, Seong RH, Solter D, Knowles BB (1993) Positive-negative selection gene targeting with the diphtheria toxin A-chain gene in mouse embryonic stem cells. Transgenic Res 2:183-190.
43. McLaughlin ME, Sandberg MA, Berson EL, Dryja TP (1993) Recessive mutations in the gene encoding the b-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nat Genet 4:130-134.
44. McLaughlin ME, Ehrhart TL, Berson EL, Dryja TP (1995) Mutation spectrum of the gene encoding the b subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa. Proc Natl Acad Sci U S A 92:3249-3253.
45. Mitamura Y, Mitamura-Aizawa S, Nagasawa T, Katome T, Eguchi H, Naito T (2012) Diagnostic imaging in patients with retinitis pigmentosa. J Med Invest 59:1-11.
46. Miyoshi G, Fishell G (2006) Directing neuron-specific transgene expression in the mouse CNS. Curr Opin Neurobiol 16:577-584.
47. Owsley C, Jackson GR, Cideciyan AV, Huang Y, Fine SL, Ho AC, Maguire MG, Lolley V, Jacobson SG (2000) Psychophysical evidence for rod vul- nerabilityinage-related macular degeneration. Invest Ophthalmol Vis Sci 41:267-273.
48. Owsley C, Jackson GR, White M, Feist R, Edwards D (2001) Delays in rod-mediated dark adaptation inearly age-related maculopathy. Ophthalmology 108:1196-1202.
49. Pang JJ, Dai X, Boye SE, Barone I, Boye SL, Mao S, Everhart D, Dinculescu A, Liu L, Umino Y, Lei B, Chang B, Barlow R, Strettoi E, Hauswirth WW (2011) Long-term retinal function and structure rescue using capsid mu tant AAV8 vector in the rd10 mouse, a model of recessive retinitis pig- mentosa. Mol Ther 19:234-242.
50. Pang JJ, Boye SL, Deng W, Kumar A, Dinculescu A, Chiodo V, Li J, Li Q, Rani A, Foster TC, Chang B, Hawes NL, Boatright JH, Hauswirth WW (2008) AAV-mediated gene therapy delays retinal degeneration in the rd10 mouse containing a recessive PDEbeta mutation. Invest Ophthalmol Vis Sci 49:4278-4283.
51. Petit L, Lhe'riteau E, Weber M, Le Meur G, Deschamps JY, Provost N, Mendes-Madeira A, Libeau L, Guihal C, Colle MA, Moullier P, Rolling F (2012) Restorationof visioninthe pde6beta-deficient dog,alarge animal model of rod-cone dystrophy. Mol Ther 20:2019-2030.
52. Petrs-Silva H, Dinculescu A, Li Q, Min SH, Chiodo V, Pang JJ, Zhong L, Zolotukhin S, Srivastava A, Lewin AS, Hauswirth WW (2009) High-efficiency transduction of the mouse retina by tyrosine-mutant AAV se-rotype vectors. Mol Ther 17:463-471.
53. Robson AG, Michaelides M, Saihan Z, Bird AC, Webster AR, Moore AT, Fitzke FW, Holder GE (2008) Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence: a review and update. Doc Ophthalmol 116: 79-89.
54. Sahni JN, Angi M, Irigoyen C, Semeraro F, Romano MR, Parmeggiani F (2011) Therapeutic challenges to retinitis pigmentosa: from neuropro-tection to gene therapy. Curr Genomics 12:276-284.
55. Sancho-Pelluz J, Tosi J, Hsu CW, Lee F, Wolpert K, Tabacaru MR, Greenberg JP, Tsang SH, Lin CS (2012) Mice with a D190N mutation in the gene encoding rhodopsin: a model for human autosomal-dominant retinitis pigmentosa. Mol Med 18:549-555.
56. Silva M, GrasJ (1979) [conditions for greater survivalofneonatally thymec-tomized Swiss mice (author's transl)]. Rev Esp Fisiol 35:85-87.
57. Sparrow JR, Blonska A, Flynn E, Duncker T, Greenberg JP, Secondi R, Ueda K, Delori FC (2013) Quantitative fundus autofluorescence in mice: correlation with HPLC quantitation of RPE lipofuscin and measurement of retina outer nuclear layer thickness. Invest Ophthalmol Vis Sci 54:2812-2820.
58. Stieger K, Lorenz B (2010) Gene therapy for vision loss: recent developments. Discov Med 10:425-433.
59. Streichert LC, Birnbach CD, Reh TA (1999) A diffusible factor from normal retinal cells promotes rod photoreceptor survival in an in vitro model of retinitis pigmentosa. J Neurobiol 39:475-490.
60. Suckow MA, Stevens KA, Wilson RP (2012) The laboratory rabbit, guinea pig, hamster, and other rodents, Ed 1. Waltham, MA: Academic.
61. Tawara A, Varner HH, Hollyfield JG (1989) Proteoglycans in the mouse interphotoreceptor matrix: II. Origin and development of proteoglycans. Exp Eye Res 48:815-839.
62. Tosi J, Davis RJ, Wang NK, Naumann M, Lin CS, Tsang SH (2011a) shRNA knockdown of guanylate cyclase 2e or cyclic nucleotide gated channel alpha 1 increases photoreceptor survival in a cGMP phosphodiesterase mouse model of retinitis pigmentosa. J Cell Mol Med 15:1778-1787.
63. Tosi J, Sancho-Pelluz J, Davis RJ, Hsu CW, Wolpert KV, Sengillo JD, Lin CS, Tsang SH (2011b) Lentivirus-mediated expressionofcDNA and shRNA slows degeneration in retinitis pigmentosa. Exp Biol Med (Maywood) 236:1211-1217.
64. Trifunović D, Sahaboglu A, Kaur J, Mencl S, Zrenner E, Ueffing M, Arango-Gonzalez B, Paquet-Durand F (2012) Neuroprotective strategies for the treatment of inherited photoreceptor degeneration. Curr Mol Med 12: 598-612.
65. Tsang SH, Gouras P, Yamashita CK, Kjeldbye H, Fisher J, Farber DB, Goff SP (1996) Retinal degeneration in mice lacking the gamma subunit of the rod cGMP phosphodiesterase. Science 272:1026-1029.
66. Tsang SH, Tsui I, Chou CL, Zernant J, Haamer E, Iranmanesh R, Tosi J, Allikmets R (2008) A novel mutation and phenotypes in phosphodies-terase 6 deficiency. Am J Ophthalmol 146:780-788.
67. Tsui I, Song B, Lin CS, Tsang S (2007) A practical approach to retinal dystrophies. Retin Physician 4:18-26.
68. Wang NK, Fine HF, Chang S, Chou CL, Cella W, Tosi J, Lin CS, Nagasaki T, Tsang SH (2009) Cellular origin of fundus autofluorescence in patients and mice with a defective NR2E3 gene. Br J Ophthalmol 93:1234-1240.
69. Wang NK, Lai CC, Liu CH, Yeh LK, Chou CL, Kong J, Nagasaki T, Tsang SH, Chien CL (2013) Originof fundus hyperautofluorescent spots, and their role in retinal degeneration in a mouse model of Goldmann-Favre syndrome. Dis Model Mech, in press.
70. Wert KJ, Skeie JM, Davis RJ, Tsang SH, Mahajan VB (2012) Subretinal injection of gene therapy vectors and stem cells in the perinatal mouse eye. J Vis Exp 69:4286.
71. Wert KJ, Davis RJ, Sancho-Pelluz J, Nishina PM, Tsang SH (2013) Gene therapy provides long-term visual function in a preclinical model of ret-initis pigmentosa. Hum Mol Genet 22:558-567.
72. Xu H, Chen M, Manivannan A, Lois N, Forrester JV (2008) Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 7:58-68.
73. Zinkernagel MS, McMenamin PG, Forrester JV, Degli-Esposti MA (2011) T cell responses in experimental viral retinitis: mechanisms, peculiarities and implications for gene therapy with viral vectors. Prog Retin Eye Res 30:275-284.